Northwest Bancshares’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,134
Closed -$590K 179
2024
Q3
$590K Sell
1,134
-228
-17% -$122K 0.1% 114
2024
Q2
$738K Buy
1,362
+96
+8% +$50.7K 0.13% 94
2024
Q1
$656K Buy
1,266
+54
+4% +$26.9K 0.1% 108
2023
Q4
$572K Sell
1,212
-115
-9% -$53.2K 0.1% 104
2023
Q3
$578K Sell
1,327
-23
-2% -$10.4K 0.11% 106
2023
Q2
$600K Sell
1,350
-142
-10% -$65.5K 0.11% 106
2023
Q1
$686K Sell
1,492
-66
-4% -$31.4K 0.13% 99
2022
Q4
$799K Sell
1,558
-190
-11% -$96.5K 0.16% 99
2022
Q3
$794K Buy
+1,748
New +$836K 0.19% 93
2022
Q2
Sell
-1,888
Closed -$927K 187
2022
Q1
$927K Sell
1,888
-64
-3% -$29.3K 0.18% 99
2021
Q4
$905K Sell
1,952
-91
-4% -$38.3K 0.18% 106
2021
Q3
$762K Sell
2,043
-122
-6% -$46.4K 0.17% 116
2021
Q2
$827K Sell
2,165
-103
-5% -$39.4K 0.19% 112
2021
Q1
$814K Buy
2,268
+11
+0.5% +$3.54K 0.19% 113
2020
Q4
$725K Sell
2,257
-2,547
-53% -$782K 0.19% 112
2020
Q3
$1.29M Buy
4,804
+544
+13% +$146K 0.33% 88
2020
Q2
$1.12M Buy
+4,260
New +$1.14M 0.31% 93

Other funds holding ELV

Northwest Bancshares's ELV Position: Q4 2024 in Review

Northwest Bancshares sold out of Elevance Health (ELV) in Q4 2024, closing a stake of 1,134 shares — an estimated $590K sold.

Northwest Bancshares first reported a position in ELV in Q2 2020 and held it in 17 quarters. The position peaked at $1.29M in Q3 2020. 1,602 funds tracked by Wall St. Rank hold ELV as of Q4 2024.

  • Northwest Bancshares reported no remaining Elevance Health position as of Q4 2024 after selling out during the quarter.
  • Northwest Bancshares sold 1,134 Elevance Health shares in Q4 2024, an estimated $590K.
  • Northwest Bancshares first reported a position in Elevance Health in Q2 2020 and held it in 17 quarters.
  • Northwest Bancshares's Elevance Health position peaked at $1.29M in Q3 2020.
  • 1,602 funds tracked by Wall St. Rank held Elevance Health as of Q4 2024.

Based on Northwest Bancshares's 13F filing for Q4 2024, filed 12 Feb 2025.